Prednisone

• A Phase 2/3 study to evaluate safety and efficacy of the combination of Bel- CHOP/ Fol-COP drugs against CHOP in newly diagnosed Peripheral … Recruiting
  2023-507803-76-00 Phase II/III 5 countries Acrotech Biopharma Inc.
• Long-term clinical trial of PQ Grass in paediatric subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by grass poll… Recruiting
  2023-508520-36-00 Phase III 7 countries Allergy Therapeutics (UK) Limited
• A Study to Evaluate Whether Healing all Bowel Wall Layers is a Superior Treatment Target in Patients with Active Crohn’s Disease (CD). Recruiting
  2023-509096-16-00 Phase IV 8 countries Alimentiv Inc.
• HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial… Recruiting
  2022-502155-65-00 Phase III 1 country Hospices Civils De Lyon
• MorningLyte: Evaluation of the benefits of the combination of mosunetuzumab plus lenalidomide versus a treatment with anti-CD20 monoclonal a… Recruiting
  2023-505436-35-00 Phase III 6 countries Lysarc
• CHOP PLUS MOSUNETUZUMAB AS FIRST LINE IN PATIENTS WITH RICHTER´S SYNDROME: A PHASE II STUDY OF THE SPANISH GROUP OF CLL (GELLC-9-RICHTER) Recruiting
  2023-505621-13-00 Phase II 1 country Grupo Espanol De Leucemia Linfocitica Cronica
• A clinical trial comparing a new treatment (MK-5684) to approved medication for advanced prostate cancer after prior hormonal therapy and ch… Recruiting
  2023-504899-25-00 Phase III 14 countries Merck Sharp & Dohme LLC
• Therapeutic approach in Colchicine-resistant Recurrent pEricarditis in children: an open-label randomized trial comparing Anakinra vs sTEroi… Recruiting
  2023-504756-96-00 Phase III 1 country Giannina Gaslini Institute For Scientific Hospitalization And Care
• FILOCLL015 - GLORIFY - A phase 2 study evaluating the bispecific CD3xCD20 antibody GLOfitamab in combination with rituximab or obinutuzumab … Recruiting
  2022-501554-11-00 Phase II 1 country French Innovative Leukemia Organization
• A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting
  2022-502113-28-00 Phase III 8 countries Regeneron Pharmaceuticals Inc.
• A multicenter randomized trial to evaluate the efficacy of pioglitazone to improve renal outcome in ANCA-associated vasculitis - RENATO Recruiting
  2022-501057-36-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• MARSUN: Evaluation of the benefits of the combination of Mosunetuzumab-Lenalidomide versus a treatment chosen by the investigator in Patient… Recruiting
  2022-501810-77-00 Phase III 5 countries Lysarc
• Benefit of transplantation after Complete Response In Patients with T-cell lymphoma Recruiting
  2022-501710-62-02 Phase IV 2 countries Lysarc
• A Long-term Study in Children and Teenagers with Ulcerative Colitis or Crohn’s Disease treated with Vedolizumab IV Recruiting
  2023-509046-36-00 Phase III 6 countries Takeda Development Center Americas Inc.
• A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults wi… Recruiting
  2022-501187-18-00 Phase III 2 countries University Of Saarland
• Study of efficacy and safety of LNP023 in participants with active lupus nephritis Class III-IV, +/- V Recruiting
  2023-509332-26-00 Phase II 5 countries Novartis Pharma AG
• The study's aim is to treat adult patients affected by Ph-like ALL, a Philadelphianegative ALL subtype, with a combination of the tyrosine k… Recruiting
  2023-510240-20-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• Study to evaluate the efficacy of immunosuppression (drugs that suppres natural immunologic response of the human body) in treatment of pati… Recruiting
  2024-517484-23-00 Phase IV 1 country Medical University Of Warsaw
• TOASST Study: Taper Or Abrupt Steroid STop? Recruiting
  2024-517334-18-00 Phase IV 1 country Kantonsspital Baden AG
• A study of Vedulizumab in Children and Teenagers with Moderate to Severe Crohn's Disease (CD) Recruiting
  2023-509045-13-00 Phase III 6 countries Takeda Development Center Americas Inc.
• Trial aimed at examinate the functionality and effectiveness of the drug "IO" in adult patients with a rare form of cancer that affect the c… Recruiting
  2023-510516-39-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• MAINEPSAN : A Prospective Comparative Randomized Double-blind Placebo-controlled In-Parallel Groups Multicenter, Study to Evaluate the remis… Recruiting
  2024-514156-33-00 Phase III 1 country Hospices Civils De Lyon
• LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting
  2023-508101-24-00 Phase III 14 countries Universitaetsklinikum Muenster AöR
• A Phase 1/2 Study with Ascending Dose in order to Evaluate the Safety and Effects on Progranulin Levels of investigational product under cod… Ended
  2022-502942-29-01 Phase I/II 2 countries Prevail Therapeutics Inc.

Showing 49–72 of 126 trials